Enhanced fasting and post-prandial plasma bile acid responses after Roux-en-Y gastric bypass surgery

Reference

• Sjöström L, Lindroos AK, Peltonen M, et al. Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351:2683–93.
   PubMed Web of Science ®Google Scholar
• Falkén Y, Hellström PM, Holst JJ, et al. Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides. J Clin Endocrinol Metab 2011;96:2227–35.
   PubMed Web of Science ®Google Scholar
• Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care 2009;32:2133–5.
   PubMed Web of Science ®Google Scholar
• Pournaras DJ, Aasheim ET, Søvik TT, et al. Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders. Br J Surg 2012;99:100–3.
   PubMed Web of Science ®Google Scholar
• Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012;366:1567–76.
   PubMed Web of Science ®Google Scholar
• Pournaras DJ, Osborne A, Hawkins SC, et al. 2010;Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg 2010;252:966–71.
   PubMed Web of Science ®Google Scholar
• Pournaras DJ, Glicksman C, Vincent RP, et al. The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology 2012;153:3613–19.
   PubMed Web of Science ®Google Scholar
• Kohli R, Bradley D, Setchell KD, et al. Weight Loss Induced by Roux-en-Y Gastric Bypass But Not Laparoscopic Adjustable Gastric Banding Increases Circulating Bile Acids. J Clin Endocrinol Metab 2013;98:708–12.
   PubMed Web of Science ®Google Scholar
• le Roux CW, Aylwin SJ, Batterham RL, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006;43:108–14.
   Google Scholar
• Angelin B, Björkhem I, Einarsson K, et al. Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum. J Clin Invest 1982;70:724–31.
   PubMed Web of Science ®Google Scholar
• Lefebvre P, Cariou B, Lien F, et al. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 2009;89:147–91.
   PubMed Web of Science ®Google Scholar
• Prawitt L, Staels B. Bile acid sequestrants: glucose-lowering mechanisms. Metab Syndr Relat Disord 2010;8:3–8.
   Google Scholar
• Garg A, Grundy SM. Cholestyramine therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. A short-term, double-blind, crossover trial. Ann Intern Med 1994;121:416–22.
   PubMed Web of Science ®Google Scholar
• Adrian TE, Gariballa S, Parekh KA, et al. Rectal taurocholate increases L cell and insulin secretion, and decreases blood glucose and food intake in obese type 2 diabetic volunteers. Diabetologia 2012;55:2343–7.
   PubMed Web of Science ®Google Scholar
• Knop FK. Bile-induced secretion of glucagon-like peptide-1: pathophysiological implications in type 2 diabetes? Am J Physiol Endocrinol Metab 2010;299:10–13.
   Google Scholar
• Song KH, Li T, Owsley E, et al. Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression. Hepatology 2009;49:297–305.
   PubMed Web of Science ®Google Scholar
• Park WH, Pak YK. Insulin-dependent suppression of cholesterol 7alpha-hydroxylase is a possible link between glucose and cholesterol metabolism. Exp Mol Med 2011;43:571–9.
   PubMedGoogle Scholar
• VanPatten S, Karkanias GB, Rossetti L, et al. Intracerebroventricular leptin regulates hepatic cholesterol metabolism. Biochem J 2004;379:229–33.
   PubMedGoogle Scholar
• Li T, Jahan A, Chiang JY. Bile acids and cytokines inhibit the human cholesterol 7 alpha-hydroxylase gene via the JNK/c-jun pathway in human liver cells. Hepatology 2006;43:1202–10.
   PubMed Web of Science ®Google Scholar
• Glicksman C, Pournaras DJ, Wright M, et al. Post-prandial plasma bile acid responses in normal weight and obese subjects. Ann Clin Biochem 2010;47:482–4.
   PubMedGoogle Scholar
• Simonen M, Dali-Youcef N, Kaminska D, et al. Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass. Obes Surg 2012;22:1473–80.
   PubMedGoogle Scholar
• Patti ME, Houten SM, Bianco AC, et al. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring) 2009;17:1671–7.
   PubMed Web of Science ®Google Scholar
• Nakatani H, Kasama K, Oshiro T, et al. Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery. Metabolism 2009;58:1400–7.
   PubMedGoogle Scholar
• Tagliacozzi D, Mozzi AF, Casetta B, et al. Quantitative analysis of bile acids in human plasma by liquid chromatography-electrospray tandem mass spectrometry: a simple and rapid one-step method. Clin Chem Lab Med 2003;41:1633–41.
   PubMed Web of Science ®Google Scholar
• Kreymann B, Williams G, Ghatei MA, et al. Glucagon-like pretide-1 7-36: a physiological incretin in man. Lancet 1987;2:300–4.
   Google Scholar
• Savage AP, Adrian TE, Carolan et al. Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut 1987;28:166–70.
   PubMed Web of Science ®Google Scholar
• Harris K, Kassis A, Major G, et al. Is the gut microbiota a new factor contributing to obesity and its metabolic disorders? J Obes 2012;2012:879151.
   PubMedGoogle Scholar
• Bigornia SJ, Farb MG, Mott MM, et al. Relation of depot-specific adipose inflammation to insulin resistance in human obesity. Nutr Diabetes 2012;2:30.
   PubMed Web of Science ®Google Scholar
• Harman-Boehm I, Blüher M, Redel H, et al. Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab 2007;92:2240–7.
   PubMed Web of Science ®Google Scholar
• Schipper HS, Prakken B, Kalkhoven E, et al. Adipose tissue-resident immune cells: key players in immunometabolism. Trends Endocrinol Metab 2012;23:407–15.
   PubMed Web of Science ®Google Scholar
• Monte SV, Caruana JA, Ghanim H, et al. Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus. Surgery 2012;151:587–93.
   PubMed Web of Science ®Google Scholar
• Cani PD, Osto M, Geurts L, et al. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 2012;3:279–88.
   PubMed Web of Science ®Google Scholar
• Li JV, Ashrafian H, Bueter et al. Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut 2011;60:1214–23.
   PubMed Web of Science ®Google Scholar
• Thomas C, Auwerx J, Schoonjan K. Bile acids and the membrane bile acid receptor TGR5-connecting nutrition and metabolism. Thyroid 2008;18:167–74.
   PubMed Web of Science ®Google Scholar
• Kumar DP, Rajagopal S, Mahavadi S, et al. Activation of transmembrane bile acid receptor TGR5 stimulates insulin secretion in pancreatic β cells. Biochem Biophys Res Commun 2012;427:600–5.
   PubMed Web of Science ®Google Scholar
• Düfer M, Hörth K, Wagner R, et al. Bile acids acutely stimulate insulin secretion of mouse β-cells via farnesoid X receptor activation and K(ATP) channel inhibition. Diabetes 2012;61:1479–89.
   PubMed Web of Science ®Google Scholar
• Steinert RE, Peterli R, Keller S, et al. Bile acids and gut peptide secretion after bariatric surgery - A 1-year prospective randomized pilot trial. Obesity (Silver Spring) 2013; doi: 10.1002/oby.20522; Epub ahead of print.
   PubMedGoogle Scholar
• Kohli R, Setchell KDR, Kirby M, et al. A Surgical Model in Male Obese Rats Uncovers Protective Effects of Bile Acids Post-Bariatric Surgery. Endocrinology 2013;154:2341–51.
   PubMed Web of Science ®Google Scholar
• Gerhard GS, Styer AM, Wood GC, et al. A Role for Fibroblast Growth Factor 19 and Bile Acids in Diabetes Remission After Roux-en-Y Gastric Bypass. Diabetes Care 2013;36:1859–64.
   PubMedGoogle Scholar
• Russell DW. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 2003;72:137–74.
   PubMed Web of Science ®Google Scholar
• Falany CN, Johnson MR, Barnes S, et al. Glycine and taurine conjugation of bile acids by a single enzyme. J Biol Chem 1994;269:19375–9.
   PubMed Web of Science ®Google Scholar
• Beckman LM, Beckman TR, Sibley SD, et al. Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass surgery. JPEN J Parenter Enteral Nutr 2011;35:169–80.
   PubMed Web of Science ®Google Scholar
• Schreuder TC, Marsman HA, Lenicek M, et al. The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance. Am J Physiol Gastrointest Liver Physiol 2010;298:440–5.
   PubMed Web of Science ®Google Scholar